Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Clinical trial NCT00228553 · COMPLETED

Trial details

NCT number: NCT00228553
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Excessive Daytime Sleepiness Narcolepsy Obstructive Sleep Apnea/Hypopnea Syndrome Chronic Shift Work Sleep Disorder

Start date: 2004-05-01
Enrollment: 743

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.